Catalina Parga
Senior Scientist, Process Development Alnylam Pharmaceuticals
Catalina Parga is a Process Development Scientist at Alnylam Pharmaceuticals, leveraging extensive expertise in oligonucleotide synthesis, process development, and chemical engineering within the biopharmaceutical sector. Based in the Boston metropolitan area, her work contributes to the advancement of novel RNA interference therapeutics.
Building on a strong foundation in chemical engineering and advanced synthesis, Catalina has demonstrated significant leadership in oligonucleotide isolation and purification. In her role as Head of Oligonucleotide Isolation and Purification at Exactmer, she was instrumental in establishing the department’s downstream process development and scale-up strategies, defining operational procedures, and overseeing departmental budgets and resource allocation. Her responsibilities included managing a team to ensure project deadlines were met and providing regular progress reports to clients, showcasing her capabilities in both technical oversight and client relations.
Seminars
- Explore how biocatalysis and enzyme engineering are enabling more efficient and scalable approaches to new modalities
- Discuss current challenges in enzymatic process development, including reaction optimization, selectivity, and process scalability
- Share perspectives on emerging opportunities for integrating enzymatic strategies into industrial biocatalysis manufacturing workflows
